Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / E••• C•••• I••••••••

G•••• C•••••• Announces Strategic Investment in E••• C•••• I•••••••• for Research

Growth investmentannouncedannounced Nov 27, 2023Fact
What happened
Target
E••• C•••• I••••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • D•••• F•••••••Deal partnerconfirmed
    “D•••• F•••••••, Partner at G•••• C•••••• added, “Rushab, Rebecca and the entire ECIR management team have built an impressive organization with a unique focus on its culture and employees that we are confident can serve as an exemplar for what quality clinical research can and should be.”
  • G•••• C••••••Sponsorconfirmed
    “G•••• C•••••• Announces Strategic Investment in E••• C•••• I•••••••• for Research | published on G•••• C••••••'s own news page gaugecapital.com”
Advisory side
  • M•••••••• W••• • E•••• L••Legal adviserconfirmed
    “M•••••••• W••• & E•••• served as legal advisor.”
Side not stated
Evidence
“G•••• C•••••• Announces Strategic Investment in E••• C•••• I•••••••• for Research”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
G•••• C•••••• Announces Strategic Investment in E••• C•••• I•••••••• for Research | Private Equity Intelligence | DFX